• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

189.31 +2.78 (+1.49%)
Official Closing Price Updated: 4:15 PM EDT, Jul 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,245,822
Open 186.24
Bid (Size) 185.00 (200)
Ask (Size) 190.39 (200)
Prev. Close 186.53
Today's Range 185.59 - 189.39
52wk Range 128.84 - 199.05
Shares Outstanding N/A
Dividend Yield 0.05%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? ↗
July 12, 2026
First Trust's 30-stock strategy delivered 53.2% returns over one year, but comes with higher concentration risk and a steeper 11-basis-point fee. 
Via The Motley Fool
Topics ETFs
News headline image
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy? ↗
July 10, 2026
Established pharmaceutical giants have delivered lower volatility and higher income than clinical-stage biotech exposure over the past five years. 
Via The Motley Fool
Topics ETFs

Performance

YTD
+12.0%
+12.0%
1 Month
+7.0%
+7.0%
3 Month
+7.7%
+7.7%
6 Month
+10.9%
+10.9%
1 Year
+46.6%
+46.6%

More News

Read More
News headline image
Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up? ↗
July 04, 2026
Via The Motley Fool
Topics ETFs
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? ↗
February 10, 2026
Via Stocktwits
News headline image
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns ↗
July 02, 2026
Via The Motley Fool
Topics ETFs
News headline image
5 Places Investors Can Hide If the AI Trade Keeps Cracking ↗
June 29, 2026
Via MarketBeat
Topics Artificial Intelligence ETFs
News headline image
MarketBeat Week in Review – 06/22 - 06/26 ↗
June 27, 2026
Via MarketBeat
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. ↗
June 23, 2026
Via MarketBeat
Topics ETFs
News headline image
2 Ways to Play the Big Pharma Patent Cliff ↗
May 15, 2026
Via MarketBeat
Topics ETFs Intellectual Property
News headline image
Corcept Therapeutics Outperforms: How a Surprise FDA Approval Ignited a Late-March Rally
March 31, 2026
Via MarketMinute
Topics ETFs Intellectual Property Stocks
News headline image
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗
March 21, 2026
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
News headline image
QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗
March 10, 2026
Via Stocktwits
Topics Initial Public Offering
News headline image
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 ↗
March 09, 2026
Via Stocktwits
News headline image
Why Did CRMD Stock Tumble Over 11% Today? ↗
March 05, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
Why Did BTAI Stock Surge 20% In Pre-Market Today? ↗
March 05, 2026
Via Stocktwits
News headline image
Why Did CDXS Stock Jump 7% Today? ↗
March 04, 2026
Via Stocktwits
News headline image
AARD Stock Slumps 54% Pre-Market – Here’s Why Analysts Are Not ‘Comfortable’ With The Suspension Of A Key Phase 3 Trial ↗
March 02, 2026
Via Stocktwits
News headline image
AUPH Stock Gains On Aurinia Pharma’s Q4 Beat, But 2026 Guidance Misses Estimates ↗
February 26, 2026
Via Stocktwits
News headline image
VIR Stock Surges 60% Pre-Market Today – Analysts Cheer Strong Cancer Data, Astellas Partnership ↗
February 24, 2026
Via Stocktwits
News headline image
ImmunityBio’s Q4 Revenue Gets A Lift From ANKTIVA Sales – IBRX Stock Gains 1% Pre-Market ↗
February 23, 2026
Via Stocktwits
News headline image
Why Did ACLX Stock Surge 80% In Pre-Market Today? ↗
February 23, 2026
Via Stocktwits
News headline image
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition ↗
February 18, 2026
Via Stocktwits
News headline image
CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial ↗
February 17, 2026
Via Stocktwits
News headline image
CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗
February 17, 2026
Via Stocktwits
News headline image
HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗
February 09, 2026
Via Stocktwits

Frequently Asked Questions

Is iShares Biotechnology ETF publicly traded?
Yes, iShares Biotechnology ETF is publicly traded.
What exchange does iShares Biotechnology ETF trade on?
iShares Biotechnology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for iShares Biotechnology ETF?
The ticker symbol for iShares Biotechnology ETF is IBB on the Nasdaq Stock Market
What is the current price of iShares Biotechnology ETF?
The current price of iShares Biotechnology ETF is 189.31
When was iShares Biotechnology ETF last traded?
The last trade of iShares Biotechnology ETF was at 07/21/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap